Genetic diagnosis of autism spectrum disorders: The opportunity and challenge in the genomics era

Critical Reviews in Clinical Laboratory Sciences

Volumn 51, Issue 5, 2014, Pages 249-262

  Jiang, Yong Hui ^a,b   Wang, Yi ^b   Xiu, Xu ^b   Choy, Kwong Wai ^c   Pursley, Amber Nolen ^d   Cheung, Sau W ^d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^c UTRECHT UNIVERSITY   (Netherlands)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Array comparative genomic hybridization; Autism spectrum disorders; Copy number variation; Prenatal diagnosis; Single nucleotide variant; Whole exome sequencing; Whole genome sequencing

Indexed keywords

AUTISM; BIOCHEMISTRY; CLINICAL EVALUATION; CLINICAL GENETICS; COPY NUMBER VARIATION; DIAGNOSTIC PROCEDURE; EXOME; EXON; FETUS ECHOGRAPHY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC VARIABILITY; GENOMICS; HERITABILITY; HIGH RISK PREGNANCY; HUMAN; INCIDENTAL FINDING; MEDICAL HISTORY; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; PEDIGREE; PHENOTYPE; PHYSICAL EXAMINATION; PLEIOTROPY; PRENATAL DIAGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; DNA SEQUENCE; GENETIC SCREENING; GENETICS;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; GENETIC TESTING; GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84907910047     PISSN: 10408363     EISSN: 1549781X     Source Type: Journal    
DOI: 10.3109/10408363.2014.910747     Document Type: Review

References (123)

1. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943;2:217-53.
2. Folstein SR, M. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry 1977;197:297-321.
3. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.
4. Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011;68:1095-102.
5. Hallmayer J, Glasson EJ, Bower C, et al. On the twin risk in autism. Am J Hum Genet 2002;71:941-6.
6. Steffenburg S, Gillberg C, Hellgren L, et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 1989;30:405-16.
7. Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpGbinding protein 2. Nat Genet 1999;23:185-8.
8. Pieretti M, Zhang FP, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991;66:817-22.
9. State MW, Levitt P. The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci 2011;14: 1499-506.
10. Buxbaum JD, Daly MJ, Devlin B, et al. The Autism Sequencing Consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Neuron 2012;76:1052-6.
11. Geschwind DH. Autism: many genes, common pathways? Cell 2008;135:391-5.
12. Schaaf CP, Goin-Kochel RP, Nowell KP, et al. Expanding the clinical spectrum of the 16p11.2 chromosomal rearrangements: three patients with syringomyelia. Eur J Hum Genet 2011;19: 152-6.
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000:70-5.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association, 2013:50-9.
15. Schaefer GB, Mendelsohn NJ, Professional P, et al. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med 2013; 15: 399-407.
16. Jacquemont ML, Sanlaville D, Redon R, et al. Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet 2006;43:843-9.
17. Beaudet AL. Autism: highly heritable but not inherited. Nat Med 2007;13:534-6.
18. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 2012;61:1-19.
19. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009;58:1-20.
20. Gregory SG, Anthopolos R, Osgood CE, et al. Association of autism with induced or augmented childbirth in North Carolina Birth Record (1990-1998) and Education Research (1997-2007) databases. JAMA Pediatr 2013;167:959-66.
21. Huguet G, Ey E, Bourgeron T. The genetic landscapes of autism spectrum disorders. Ann Rev Genom Hum Genet 2013;14: 191-213.
22. Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 2012;22:229-37.
23. Stankiewicz P, Inoue K, Bi W, et al. Genomic disorders: genome architecture results in susceptibility to DNA rearrangements causing common human traits. Cold Spring Harb Symp Quant Biol 2003;68:445-54.
24. Williams CA, Lossie A, Driscoll D. Angelman syndrome: mimicking conditions and phenotypes. Am J Med Genet 2001; 101:59-64.
25. Phelan MC. Deletion 22q13.3 syndrome. Orphanet J Rare Dis 2008;3:14-20.
26. Laje G, Morse R, Richter W, et al. Autism spectrum features in Smith-Magenis syndrome. Am J Med Genet C Semin Med Genet 2010;154C:456-62.
27. Potocki L, Bi W, Treadwell-Deering D, et al. Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am J Hum Genet 2007;80:633-49.
28. Cook Jr EH, Lindgren V, Leventhal BL, et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 1997;60:928-34.
29. Roberts SE, Dennis NR, Browne CE, et al. Characterisation of interstitial duplications and triplications of chromosome 15q11- q13. Hum Genet 2002;110:227-34.
30. Ingason A, Kirov G, Giegling I, et al. Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. Am J Psychiatry 2011;168:408-17.
31. Thomas NS, Durkie M, Potts G, et al. Parental and chromosomal origins of microdeletion and duplication syndromes involving 7q11.23, 15q11-q13 and 22q11. Eur J Hum Genet 2006;14:831-7.
32. Boyar FZ, Whitney MM, Lossie AC, et al. A family with a grandmaternally derived interstitial duplication of proximal 15q. Clin Genet 2001;60:421-30.
33. Bucan M, Abrahams BS, Wang K, et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 2009;5:e1000536.
34. Wang NJ, Liu D, Parokonny AS, et al. High-resolution molecular characterization of 15q11-q13 rearrangements by array comparative genomic hybridization (array CGH) with detection of gene dosage. Am J Hum Genet 2004;75:267-81.
35. Gurrieri F, Battaglia A, Torrisi L, et al. Pervasive developmental disorder and epilepsy due to maternally derived duplication of 15q11-q13. Neurology 1999;52:1694-7.
36. Depienne C, Moreno-De-Luca D, Heron D, et al. Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol Psychiatry 2009;66:349-59.
37. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-64.
38. Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010;466:368-72.
39. Sanders SJ, Ercan-Sencicek AG, Hus V, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011;70:863-85.
40. Celestino-Soper PB, Shaw CA, Sanders SJ, et al. Use of array CGH to detect exonic copy number variants throughout the genome in autism families detects a novel deletion in TMLHE. Hum Mol Genet 2011;20:4360-70.
41. Toro R, Konyukh M, Delorme R, et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 2010;26:363-72.
42. Boone PM, Bacino CA, Shaw CA, et al. Detection of clinically relevant exonic copy-number changes by array CGH. Hum Mutat 2010;31:1326-42.
43. Schaaf CP, Boone PM, Sampath S, et al. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions. Eur J Hum Genet 2012;20:1240-7.
44. Nagamani SC, Erez A, Ben-Zeev B, et al. Detection of copynumber variation in AUTS2 gene by targeted exonic array CGH in patients with developmental delay and autistic spectrum disorders. Eur J Hum Genet 2013;21:343-6.
45. Beunders G, Voorhoeve E, Golzio C, et al. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus. Am J Hum Genet 2013; 92:210-20.
46. Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007;39: 25-7.
47. Bonaglia MC, Giorda R, Mani E, et al. Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet 2006;43:822-8.
48. Wilson HL, Wong AC, Shaw SR, et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 2003;40:575-84.
49. Boccuto L, Lauri M, Sarasua SM, et al. Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet 2013;21:310-16.
50. Moessner R, Marshall CR, Sutcliffe JS, et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 2007;81:1289-97.
51. Talkowski ME, Mullegama SV, Rosenfeld JA, et al. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet 2011;89:551-63.
52. Zweier C, de Jong EK, Zweier M, et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 2009;85:655-66.
53. Laumonnier F, Bonnet-Brilhault F, Gomot M, et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 2004;74:552-7.
54. Arking DE, Cutler DJ, Brune CW, et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008;82:160-4.
55. Chahrour MH, Yu TW, Lim ET, et al. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet 2012;8:e1002635.
56. Iossifov I, Ronemus M, Levy D, et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012;74:285-99.
57. Neale BM, Kou Y, Liu L, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012;485: 242-5.
58. O'Roak BJ, Vives L, Girirajan S, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012;485:246-50.
59. Michaelson JJ, Shi Y, Gujral M, et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 2012;151:1431-42.
60. Jiang YH, Yuen RK, Jin X, et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet 2013;93:249-63.
61. Sanders SJ, Murtha MT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012;485:237-41.
62. Bi C, Wu J, Jiang T, et al. Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility. Hum Mutat 2012;33:1635-8.
63. Shi L, Zhang X, Golhar R, et al. Whole-genome sequencing in an autism multiplex family. Mol Autism 2013;4:8. doi: 10.1186/2040-2392-4-8.
64. Yu TW, Chahrour MH, Coulter ME, et al. Using whole-exome sequencing to identify inherited causes of autism. Neuron 2013; 77:259-73.
65. Lim ET, Raychaudhuri S, Sanders SJ, et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 2013;77:235-42.
66. Szatmari P, Paterson AD, Zwaigenbaum L, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007;39:319-28.
67. Devlin B, Melhem N, Roeder K. Do common variants play a role in risk for autism? Evidence and theoretical musings. Brain Res 2011;1380:78-84.
68. Wang K, Zhang H, Ma D, et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009; 459:528-33.
69. Weiss LA. Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans. Expert Rev Mol Diagn 2009;9:795-803.
70. Anney R, Klei L, Pinto D, et al. A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet 2010;19: 4072-82.
71. Weiss LA, Arking DE, Daly MJ, et al. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009;461: 802-8.
72. Anney R, Klei L, Pinto D, et al. Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet 2012;21:4781-92.
73. Zecavati N, Spence SJ. Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr Neurol Neurosci Rep 2009;9: 129-36.
74. Johnson CP, Myers SM, American Academy of Pediatrics Council on Children with Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007;120: 1183-215.
75. Zwaigenbaum L, Bryson S, Lord C, et al. Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants. Pediatrics 2009;123: 1383-91.
76. Shen Y, Dies KA, Holm IA, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 2010;125: e727-35.
77. Herman GE, Henninger N, Ratliff-Schaub K, et al. Genetic testing in autism: how much is enough? Genet Med 2007;9:268-74.
78. Ou Z, Kang SH, Shaw CA, et al. Bacterial artificial chromosomeemulation oligonucleotide arrays for targeted clinical arraycomparative genomic hybridization analyses. Genet Med 2008; 10:278-89.
79. Wiszniewska J, Bi W, Shaw C, et al. Combined array CGH plus SNP genome analyses in a single assay for optimized clinical testing. Eur J Hum Genet 2014;22:79-87.
80. Peiffer DA, Le JM, Steemers FJ, et al. High-resolution genomic profiling of chromosomal aberrations using Infinium wholegenome genotyping. Genome Res 2006;16:1136-48.
81. Schwartz S. Clinical utility of single nucleotide polymorphism arrays. Clin Lab Med 2011;31:581-94.
82. Papenhausen P, Schwartz S, Risheg H, et al. UPD detection using homozygosity profiling with a SNP genotyping microarray. Am J Med Genet A 2011;155A:757-68.
83. Alkan C, Coe BP, Eichler EE. Genome structural variation discovery and genotyping. Nat Rev Genet 2011;12:363-76.
84. Gamsiz ED, Viscidi EW, Frederick AM, et al. Intellectual disability is associated with increased runs of homozygosity in simplex autism. Am J Hum Genet 2013;93:103-9.
85. Cohen D, Pichard N, Tordjman S, et al. Specific genetic disorders and autism: clinical contribution towards their identification. J Autism Dev Disord 2005;35:103-16.
86. Myers SM, Johnson CP, American Academy of Pediatrics Council on Children with Disabilities. Management of children with autism spectrum disorders. Pediatrics 2007;120: 1162-82.
87. Rehm HL, Bale SJ, Bayrak-Toydemir P, et al. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 2013;15:733-47.
88. Jacob HJ. Next-generation sequencing for clinical diagnostics. N Engl J Med 2013;369:1557-8.
89. Gahl WA, Markello TC, Toro C, et al. The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases. Genet Med 2012;14:51-9.
90. Ng SB, Turner EH, Robertson PD, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009; 461:272-6.
91. Hoischen A, van Bon BW, Rodriguez-Santiago B, et al. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat Genet 2011;43:729-31.
92. Gilissen C, Hoischen A, Brunner HG, et al. Unlocking Mendelian disease using exome sequencing. Genome Biol 2011;12:228-239.
93. Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013;369:1502-11.
94. Rodriguez-Flores JL, Fakhro K, Hackett NR, et al. Exome sequencing identifies potential risk variants for Mendelian disorders at high prevalence in Qatar. Hum Mutat 2014;35: 105-16.
95. Patel AB, Hays SA, Bureau I, et al. A target cell-specific role for presynaptic Fmr1 in regulating glutamate release onto neocortical fast-spiking inhibitory neurons. J Neurosci 2013;33:2593-604.
96. Stankiewicz P, Pursley AN, Cheung SW. Challenges in clinical interpretation of microduplications detected by array CGH analysis. Am J Med Genet A 2010;152A:1089-100.
97. Hehir-Kwa JY, Pfundt R, Veltman JA, et al. Pathogenic or not?. Assessing the clinical relevance of copy number variants. Clin Genet 2013;84:415-21.
98. Grabrucker AM, Knight MJ, Proepper C, et al. Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J 2011;30:569-81.
99. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008; 82:477-88.
100. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008;358:667-75.
101. Golzio C, Willer J, Talkowski ME, et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 2012;485:363-7.
102. Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013;339:819-23.
103. Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science 2013;339:823-6.
104. Leblond CS, Heinrich J, Delorme R, et al. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 2012;8:e1002521.
105. El-Fishawy P, State MW. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr Clin North Am 2010;33:83-105.
106. Lupski JR, Belmont JW, Boerwinkle E, et al. Clan genomics and the complex architecture of human disease. Cell 2011;147:32-43.
107. Zhu L, Wang X, Li XL, et al. Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders. Hum Mol Genet 2014;23:1563-78.
108. Jiang YH, Sahoo T, Michaelis RC, et al. A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A 2004;131:1-10.
109. Samaco RC, Hogart A, LaSalle JM. Epigenetic overlap in autismspectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet 2005;14:483-92.
110. Green RC, MD, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013:15:565-74.
111. Kumar RA, KaraMohamed S, Sudi J, et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008; 17: 628-38.
112. Walters RG, Jacquemont S, Valsesia A, et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010;463:671-5.
113. Bochukova EG, Huang N, Keogh J, et al. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 2010; 463:666-70.
114. Shen Y, Chen X, Wang L, et al. Intra-family phenotypic heterogeneity of 16p11.2 deletion carriers in a three-generation Chinese family. Am J Med Genet B Neuropsychiatr Genet 2011; 156:225-32.
115. Shinawi M, Liu P, Kang SH, et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 2010;47:332-41.
116. Puvabanditsin S, Nagar MS, Joshi M, et al. Microdeletion of 16p11.2 associated with endocardial fibroelastosis. Am J Med Genet A 2010;152A:2383-6.
117. Miller DT NR, Sobeih MM, Shen Y, Wu BL, Hanson E. 16p11.2 microdeletion. In: Pagon RA, Adam MP, Bird TD, et al., eds. GeneReviews [Internet]. Seattle (WA): University of Washington; 1993-2014. 2009 Sep 22 [updated 2011 Oct 27].
118. McCarthy SE, Makarov V, Kirov G, et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009;41: 1223-7.
119. Simons Vip Consortium. Simons Variation in Individuals Project (Simons VIP): a genetics-first approach to studying autism spectrum and related neurodevelopmental disorders. Neuron 2012;73:1063-7.
120. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012; 367:2175-84.
121. Law LW, Lau TK, Fung TY, et al. De novo 16p13.11 microdeletion identified by high-resolution array CGH in a fetus with increased nuchal translucency. BJOG 2009;116:339-43.
122. Poot M, Verrijn Stuart AA, van Daalen E, et al. Variable behavioural phenotypes of patients with monosomies of 15q26 and a review of 16 cases. Eur J Med Genet 2013;56:346-50.
123. Choy KW, Setlur SR, Lee C, et al. The impact of human copy number variation on a new era of genetic testing. BJOG 2010;117: 391-8.